Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Poseida Therapeutics, Inc. - Common Stock (NQ:PSTX)

9.500 UNCHANGED
Last Price Updated: 4:00 PM EST, Jan 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 9.500
Bid (Size) 9.530 (1)
Ask (Size) 9.550 (50)
Prev. Close 9.500
Today's Range 9.500 - 9.500
52wk Range 2.320 - 9.600
Shares Outstanding 86,916,199
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
PSTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Poseida Therapeutics, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PWOD, RVNC, B, PSTX on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire

Performance

YTD
+1.1%
+1.1%
1 Month
N/A
N/A
3 Month
N/A
N/A
6 Month
N/A
N/A
1 Year
+299.2%
+299.2%

More News

Read More
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates B, ZUO, PSTX on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
Where Poseida Therapeutics Stands With Analysts
Via Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Pactiv Evergreen Inc. (Nasdaq – PTVE), Enterprise Bancorp, Inc. (Nasdaq Global Select Market – EBTC), The Interpublic Group of Companies, Inc. (NYSE – IPG), Poseida
From Brodsky & Smith LLC
Via GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PSTX, AVTE, GATO on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Poseida Therapeutics, Inc. (Nasdaq – PSTX), Gatos Silver, Inc. (NYSE - GATO), Micropac Industries, Inc. (OTC - MPAD), Aerovate Therapeutics, Inc. (Nasdaq - AVTE)
From Brodsky & Smith LLC
Via GlobeNewswire
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
POSEIDA THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Poseida Therapeutics, Inc. - PSTX
From Kahn Swick & Foti, LLC
Via Business Wire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PSTX, ZUO, MNTX on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Poseida Therapeutics, Inc. (Nasdaq – PSTX), Air Transport Services Group, Inc. (Nasdaq– ATSG), Micropac Industries, Inc. (OTC - MPAD), Aerovate Therapeutics, Inc.
From Brodsky & Smith LLC
Via GlobeNewswire
Crude Oil Moves Lower; Dick's Sporting Goods Earnings Top Views
Via Benzinga
Nasdaq Rises 100 Points; Abercrombie & Fitch Shares Fall After Q3 Results
Via Benzinga
US Stocks Mixed; Best Buy Posts Downbeat Earnings
Via Benzinga
Shareholder Alert: Ademi LLP investigates whether Poseida Therapeutics, Inc. is obtaining a Fair Price for its Public Shareholders
From Ademi LLP
Via Business Wire
Roche's Proposed Acquisition Of Poseida Therapeutics Poised To Establish New Core Capability In Cell Therapy For Cancer And Autoimmune Diseases: Details
Via Benzinga
PSTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Poseida Therapeutics, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Why Poseida Therapeutics Shares Are Trading Higher By 219%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Best Buy, HP And 3 Stocks To Watch Heading Into Tuesday
Via Benzinga
MaxCyte Appoints Cynthia Collins to its Board of Directors
From MaxCyte, Inc
Via GlobeNewswire
PSTX Stock Earnings: Poseida Therapeutics Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
PSTX Stock Earnings: Poseida Therapeutics Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga

Frequently Asked Questions

Is Poseida Therapeutics, Inc. - Common Stock publicly traded?
Yes, Poseida Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Poseida Therapeutics, Inc. - Common Stock trade on?
Poseida Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Poseida Therapeutics, Inc. - Common Stock?
The ticker symbol for Poseida Therapeutics, Inc. - Common Stock is PSTX on the Nasdaq Stock Market
What is the current price of Poseida Therapeutics, Inc. - Common Stock?
The current price of Poseida Therapeutics, Inc. - Common Stock is 9.500
When was Poseida Therapeutics, Inc. - Common Stock last traded?
The last trade of Poseida Therapeutics, Inc. - Common Stock was at 01/07/25 04:00 PM ET
What is the market capitalization of Poseida Therapeutics, Inc. - Common Stock?
The market capitalization of Poseida Therapeutics, Inc. - Common Stock is 825.70M
How many shares of Poseida Therapeutics, Inc. - Common Stock are outstanding?
Poseida Therapeutics, Inc. - Common Stock has 826M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.